Related Experiment Video

Updated: Jun 9, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

42.8K

Reply to Masters: Recombinant coronavirus balances biosafety and benefit

Jonathan W Yewdell1

  • 1Cellular Biology Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute for Allergy and infectious Diseases, Bethesda, MD 20892.

Proceedings of the National Academy of Sciences of the United States of America
|October 21, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

58.9K
Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone08:10

Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone

Published on: June 24, 2019

26.7K

Related Concept Videos

Recombinant DNA01:09

Recombinant DNA

Overview
93.3K